Literature DB >> 28591567

A role for dystroglycan in the pathophysiology of acute leukemic cells.

Lea Alonso-Rangel1, Tizziani Benítez-Guerrero1, Ivette Martínez-Vieyra1, Bulmaro Cisneros2, Adolfo Martínez-Tovar3, Steve J Winder4, Doris Cerecedo5.   

Abstract

AIMS: Previous reports have demonstrated that alterations or reduced expression of Dystroglycan (Dg) complex (αDg and βDg subunits) are related to progression and severity of neoplastic solid tissues. Therefore we determined the expression pattern and subcellular distribution of Dg complex in Acute Myeloid Leukemia (AML) primary blasts (M1, M2, and M3 phenotypes), as well as HL-60 and Kasumi-1 leukemia cell lines. Additionally, we evaluated the relative expression of the main enzymes controlling α-Dg glycosylation to ascertain the post-translational modifications in the leukemia cell phenotype. MAIN
METHODS: Primary leukemia blasts and leukemia cell lines were processed by confocal analysis to determine the subcellular distribution of α-Dg, β-Dg, and phosphorylated β-Dg (Y892), to evaluate the expression pattern of the different Dg species we performed Western Blot (WB) assays, while the messenger RNA (mRNA) expression of enzymes involved in α-Dg glycosylation, such as POMGnT1, POMT1, POMT2, LARGE, FKTN, and FKRP, were evaluated by qualitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR). Finally, in an attempt to ameliorate the leukemia cell phenotype, we transfected leukemia cells with a plasmid expressing the Dg complex. KEY
FINDINGS: The Dg complex was altered in leukemia cells, including decreased mRNA, protein, and α-Dg glycosylated levels, mislocalization of β-Dg, and a diminution of mRNA expression of LARGE in patients leukemia blasts and in cell lines. Interestingly, the exogenous expression of Dg complex promoted filopodial formation, differentiation, and diminished proliferation, attenuating some HL-60 and Kasumi cells characteristics. SIGNIFICANCE: Dg complex integrity and balance are required for a proper hematopoietic cell function, in that its disruption might contribute to leukemia pathophysiology.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; HL-60 cells; Kasumi-1 cells; Macrophage-like cells; Phagocytosis

Mesh:

Substances:

Year:  2017        PMID: 28591567     DOI: 10.1016/j.lfs.2017.06.004

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

Review 1.  The Duchenne muscular dystrophy gene and cancer.

Authors:  Leanne Jones; Michael Naidoo; Lee R Machado; Karen Anthony
Journal:  Cell Oncol (Dordr)       Date:  2020-11-14       Impact factor: 6.730

2.  Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.

Authors:  Marcela P Cataldi; Peijuan Lu; Anthony Blaeser; Qi Long Lu
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919

3.  Duchenne muscular dystrophy-like phenotype in an LGMD2I patient with novel FKRP gene variants.

Authors:  Tetsuya Okazaki; Kaori Matsuura; Noriko Kasagi; Kaori Adachi; Masachika Kai; Mariko Okubo; Ichizo Nishino; Eiji Nanba; Yoshihiro Maegaki
Journal:  Hum Genome Var       Date:  2020-04-20

4.  Meta-Analytic Comparison of Global RNA Transcriptomes of Acute and Chronic Myeloid Leukemia Cells Reveals Novel Gene Candidates Governing Myeloid Malignancies.

Authors:  Staša Jurgec; Gregor Jezernik; Mario Gorenjak; Tomaž Büdefeld; Uroš Potočnik
Journal:  Cancers (Basel)       Date:  2022-09-26       Impact factor: 6.575

5.  The Nuclear Pore Complex: A Target for NS3 Protease of Dengue and Zika Viruses.

Authors:  Luis Adrián De Jesús-González; Margot Cervantes-Salazar; José Manuel Reyes-Ruiz; Juan Fidel Osuna-Ramos; Carlos Noe Farfán-Morales; Selvin Noé Palacios-Rápalo; José Humberto Pérez-Olais; Carlos Daniel Cordero-Rivera; Arianna M Hurtado-Monzón; Fernando Ruíz-Jiménez; Ana Lorena Gutiérrez-Escolano; Rosa María Del Ángel
Journal:  Viruses       Date:  2020-05-26       Impact factor: 5.048

6.  Circular RNA CpG island hypermethylation-associated silencing in human cancer.

Authors:  Humberto J Ferreira; Veronica Davalos; Manuel Castro de Moura; Marta Soler; Montserrat Perez-Salvia; Alberto Bueno-Costa; Fernando Setien; Sebastian Moran; Alberto Villanueva; Manel Esteller
Journal:  Oncotarget       Date:  2018-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.